Drugs / rMenB+OMV NZ
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00944034 | Jul 2009 → Aug 2011 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rMenB+OMV NZ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00944034 ↗ |
| Modality | Vaccine | “4CMenB is a multi-component vaccine against MenB” PMID 33020485 ↗ Oct 2020 |